Table 2.
Changes in clinical and laboratory parameters from baseline to 1-year reassessment (n=43)
| Variable | Baseline | One-year reassessment | P value |
|---|---|---|---|
| BMI, kg/m2 | 24.4±2.7 | 25.6±5.2 | 0.083 |
| HbA1c, % | 5.5±0.3 | 5.7±0.2 | <0.001 |
| Fasting glucose, mmol/L | 5.06±0.44 | 5.17±0.45 | 0.089 |
| 30-minute glucose, mmol/L | 8.81±1.64 | 9.13±1.75 | 0.126 |
| 1-hour glucose, mmol/L | 8.65±2.25 | 9.47±2.60 | 0.014 |
| 2-hour glucose, mmol/L | 6.52±1.91 | 6.86±1.83 | 0.165 |
| C-peptidea, nmol/L | 0.67 (0.54–0.84) | 0.67 (0.54–0.92) | 0.835 |
| HOMA-IRa | 1.39 (0.91–2.21) | 1.47 (1.14–2.22) | 0.235 |
| HOMA-βa | 89.5 (64.2–122.2) | 89.4 (53.8–106.2) | 0.679 |
| Matsuda indexa | 5.40 (3.51–9.64) | 4.94 (2.81–6.32) | 0.007 |
Values are presented as mean±standard deviation or median (interquartile range).
BMI, body mass index; HbA1c, glycosylated hemoglobin; HOMA-IR, homeostasis model assessment of insulin resistance; HOMA-β, homeostasis model assessment of β-cell function.
a
Logarithmically transformed before analyses.